[图书][B] Les infections urinaires de la femme

F Lecomte - 1999 - books.google.com
Le cancer du poumon n'existe pas (anatomopathologie).......... De la difficulté d'être
anatomopathologiste 5115 De la difficulté de classer les cancers bronchiques..... 17 …

Streptokinase inhibits pulmonary tumor seeding in an animal experimental model

P McCulloch, A Choy, AD Purushotham… - Journal of surgical …, 1994 - Wiley Online Library
One aspect of the metastatic process involves entrapment of tumor cells within the
microcirculation of organs in a “fibrin‐platelet mesh.” We postulate that destruction of this …

Small cell lung cancer: biological and therapeutic aspects

CA Kristensen, PB Jensen, HS Poulsen… - Critical reviews in …, 1996 - Elsevier
A&WWWIS: A, doxorubkin; Al&IT, autoiogous bone marrow transplantation; ACNU, see N
beiow; ACTH. adrenocorticotropk hormone; ADH. ttddbtk htt~ t~ AN, absolute neutrophik …

Streptokinase increases the sensitivity of colon cancer cells to chemotherapy by gemcitabine and cis-platine in vitro

V Bobek, D Pinterova, K Kolostova, M Boubelik… - Cancer letters, 2006 - Elsevier
The aim was to determine the effect of fybrinolytic therapy by streptokinase on chemotherapy
and radiation response in human colon cancer cells. The cells were treated with different …

[HTML][HTML] Anticoagulation, ferrotoxicity and the future of translational lung cancer research

LR Zacharski - Translational lung cancer research, 2016 - ncbi.nlm.nih.gov
Numerous studies have shown that elements of coagulation reactions mediate tumor cell
proliferation, motility (invasiveness), tissue remodeling and metastasis. Coagulation …

Studies of possible mechanisms for the effect of urokinase therapy in small cell carcinoma of the lung

KR Meehan, LR Zacharski, LH Maurer… - Blood coagulation & …, 1995 - journals.lww.com
Urokinase-type plasminogen activator has been administered by other investigators to
patients with small cell carcinoma of the lung (SCCL) in an attempt to induce lysis of fibrin …

A rebuttal: vitamin K antagonists and cancer survival

LR Zacharski, WG Henderson - Thrombosis and haemostasis, 2002 - thieme-connect.com
1TQ ietters to the Editor because it is used commonly in patients with malignancy
complicated by deep vein thrombosis and can be given chronically on an outpatient basis …

The fibrinolytic system in cancer

G Lugassy, A Klepfish - Thrombosis and Cancer, 2004 - taylorfrancis.com
The fibrinolytic system in cancer Page 1 5 The fibrinolytic system in cancer Gilles Lugassy and
Abraham Klepfish The fibrinolytic (plasminogen–plasmin proteolytic enzyme) system is …

Antimalignant properties of antithrombotic agents

CPW Klerk, SM Smorenburg… - Thrombosis and cancer …, 2004 - books.google.com
Because of the high risk of thrombosis, cancer patients often receive anticoagulants as
prophylaxis or treatment. It has been suggested that antithrombotic agents influence cancer …

[引用][C] Precise Depleting Fibrin and Modulating Tumor Mechanics with Hydroxyethyl Starch-Based Smart Nanomedicine for Enhanced Antitumor Efficacy

Z Li, J Chen, Z Zhang, Y Li, H Zeng, Z Li, C Wang, C Xu… - Available at SSRN 4102464